What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Surgery
Her main research concerns Internal medicine, Physical therapy, Rheumatoid arthritis, Clinical trial and Rheumatology.
Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Placebo and Surgery.
Her Physical therapy research incorporates elements of Quality of life, Quality of life, Active treatment, Severity of illness and Etanercept.
The study incorporates disciplines such as Pharmacology, Immunopathology and Arthritis in addition to Rheumatoid arthritis.
Her studies deal with areas such as Osteoarthritis, Adalimumab and MEDLINE as well as Clinical trial.
Her work deals with themes such as Disease activity, Psoriatic arthritis and Response criteria, which intersect with Rheumatology.
Her most cited work include:
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritis (2276 citations)
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritis (2276 citations)
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials (993 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Internal medicine, Rheumatoid arthritis, Physical therapy, Randomized controlled trial and Rheumatology.
Her Internal medicine research integrates issues from Placebo and Surgery.
Her Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Adverse effect, Methotrexate and Arthritis.
The study incorporates disciplines such as Observational study, Clinical trial, Alternative medicine, Disease and Severity of illness in addition to Physical therapy.
Her Clinical trial research integrates issues from Osteoarthritis, MEDLINE and Intensive care medicine.
Her Rheumatology research is multidisciplinary, relying on both Orthopedic surgery and Family medicine.
She most often published in these fields:
- Internal medicine (63.20%)
- Rheumatoid arthritis (39.22%)
- Physical therapy (36.62%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (63.20%)
- In patient (15.61%)
- Rheumatoid arthritis (39.22%)
In recent papers she was focusing on the following fields of study:
Vibeke Strand focuses on Internal medicine, In patient, Rheumatoid arthritis, Randomized controlled trial and Placebo.
Her Rheumatology, Adalimumab, Quality of life, Psoriatic arthritis and Minimal clinically important difference study are her primary interests in Internal medicine.
Her work deals with themes such as Arthritis, Gastroenterology, Prednisone, Orthopedic surgery and Adverse effect, which intersect with Rheumatology.
The concepts of her Rheumatoid arthritis study are interwoven with issues in Visual analogue scale, Once daily, Methotrexate and Disease activity.
Her research integrates issues of Tofacitinib, Clinical trial and Subgroup analysis in her study of Randomized controlled trial.
Her Clinical trial study integrates concerns from other disciplines, such as Physical function, MEDLINE and Family medicine.
Between 2018 and 2021, her most popular works were:
- OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies (27 citations)
- Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study. (22 citations)
- Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond (19 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
